UPLOAD Filing
InMed Pharmaceuticals Inc.
Date: March 25, 2026 · CIK: 0001728328 · Accession: 0000000000-26-003031
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294503
Letter
Re: InMed Pharmaceuticals Inc. Registration Statement on Form S-3 Filed March 20, 2026 File No. 333-294503 Dear Eric Adams:
March 25, 2026
Eric Adams Chief Executive Officer InMed Pharmaceuticals Inc. Suite 1445 885 West Georgia St. Vancouver, British Columbia Canada V6C 3E8
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Scott Saks, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 25, 2026 Eric Adams Chief Executive Officer InMed Pharmaceuticals Inc. Suite 1445 885 West Georgia St. Vancouver, British Columbia Canada V6C 3E8 Re: InMed Pharmaceuticals Inc. Registration Statement on Form S-3 Filed March 20, 2026 File No. 333-294503 Dear Eric Adams: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Scott Saks, Esq. </TEXT> </DOCUMENT>